Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Share News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
840.40    -4.20 (-0.50%)
Bid:
837.40
Ask:
838.20
Spread: 0.80 (0.096%)
Market Cap: £10.55b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Informa optimistic after solid 2023

Thu, 11th Jan 2024 07:23

(Sharecast News) - Events, digital services and business information specialist Informa reported a robust 2023 performance in a trading update on Thursday, alongside optimism over further growth in 2024.

The company said it expected to achieve a 2023 underlying revenue growth of about 30%, with reported revenue of over £3.17bn, adjusted operating profit of around £845m, and free cash flow of over £600m.

For 2024, Informa anticipated high single-digit underlying revenue growth, with reported revenue projected to be between £3.43bn and £3.48bn, and adjusted operating profit expected to range from £945m to £965m.

The company's strong performance was leading to improving shareholder returns, with a significant portion of the current share buyback programme completed by year-end and a substantial increase in the 2023 dividend.

Informa said its B2B digital services were also set to experience accelerated growth following the announcement of the combination of Informa Tech's digital businesses with US-based TechTarget, which was expected to elevate annual B2B revenues to around £3bn after completion in the second half of 2024.

Additionally, the company expected continued growth in its academic markets, with an underlying revenue growth target of approximately 4% for 2024.

Informa said its positive outlook was underpinned by its strong position in live and on-demand B2B events, specialist knowledge, and high-growth B2B markets such as pharma, healthcare, technology, health and nutrition, beauty, and aviation, as well as its international reach and solid balance sheet.

"Informa delivered a standout performance in 2023 and we are committing to further strong growth in 2024," said group chief executive officer Stephen Carter.

At 0852 GMT, shares in Informa were down 2.11% at 768.6p.

Reporting by Josh White for Sharecast.com.

Related News

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi
6 May 2026

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

Informa News

Informa Tech re-brands research and analysis business "Omdia"
5 Feb 2020

Informa Tech re-brands research and analysis business "Omdia"

LONDON, Feb 5 (Reuters) - British publishing and events group Informa is creating a new tech research house called Omdia, combining its Ovum, Heavy ...

Micro Focus Chair Steps Down As Results Fall Short Of Estimates
4 Feb 2020

Micro Focus Chair Steps Down As Results Fall Short Of Estimates

Micro Focus Chair Steps Down As Results Fall Short Of Estimates

Friday broker round-up
31 Jan 2020

Friday broker round-up

(Sharecast News) - Hargreaves Lansdown: Liberum upgrades to buy with a target price of 2,125p.

Tuesday broker round-up
28 Jan 2020

Tuesday broker round-up

(Sharecast News) - BAE Systems: Barclays upgrades to overweight with a target price of 760p.

UK BROKER RATINGS SUMMARY: Goldman Raises Auto Trader And Cuts WPP
20 Jan 2020

UK BROKER RATINGS SUMMARY: Goldman Raises Auto Trader And Cuts WPP

UK BROKER RATINGS SUMMARY: Goldman Raises Auto Trader And Cuts WPP

CORRECTED-BUZZ-European Media: GS expects twists and turnarounds in 2020
20 Jan 2020

CORRECTED-BUZZ-European Media: GS expects twists and turnarounds in 2020

(Corrects 7th bullet to show WPP was cut to "neutral", not "sell")** Goldman Sachs sees the media sector outperforming the broader market in 2020 on...

Publisher Springer Nature revives IPO plans, new bank consortium -sources
16 Jan 2020

Publisher Springer Nature revives IPO plans, new bank consortium -sources

By Arno SchuetzeFRANKFURT, Jan 16 (Reuters) - Springer Nature, the publisher of science magazines Nature and Scientific American, is reviving plans ...

UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight
16 Jan 2020

UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight

UK BROKER RATINGS SUMMARY: Barclays Downgrades Glaxo To Underweight